Esperion Therapeutics Inc (ESPR)
Cost of Revenue
$34.57M
Quarterly · Period ending: · USD
ESPR Cost of Revenue
Latest reported$34.57Mperiod ending
Latest reported$34.57Mperiod ending
ESPR Quarterly Cost of Revenue ($405.06K → $34.57M)
Quarterly cost of revenue
High-resolution chart · PNG
ESPR cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 34,573,000 | |
| 27,854,000 | |
| 55,420,000 | |
| 28,543,000 | |
| 31,538,000 | |
| 25,631,000 | |
| 17,286,000 | |
| 15,609,000 | |
| 10,075,000 | |
| 11,452,000 | |
| 13,377,000 | |
| 6,786,000 | |
| 11,652,000 | |
| 4,160,000 | |
| 6,506,000 | |
| 9,176,000 | |
| 7,125,000 | |
| 5,075,000 | |
| 5,558,000 | |
| 1,800,000 | |
| 1,784,000 | |
| 1,688,000 | |
| 275,000 | |
| 398,000 | |
| 31,000 | |
| 38,234,000 | |
| 48,281,000 | |
| 42,788,000 | |
| 46,308,000 | |
| 49,473,000 | |
| 41,551,000 | |
| 39,524,000 | |
| 40,940,000 | |
| 147,603,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 742,000 | |
| 715,000 | |
| -493,000 | |
| 445,000 | |
| 429,000 | |
| 405,056 |